Nelarabine Injection: Therapy for T-cell Acute Lymphoblastic

1
Atriance Nelarabine

•  T-cell acute lymphoblastic

2
Atriance Common Side Effects

• Fever
• Headache
• Swelling of the extremities.
• Nausea
• Tremor
• Rash

3
Nelarabine injection is an antineoplastic agent,
typically employed to treat adults and children
aged 1 year and older with T-cell acute
lymphoblastic leukemia and T-cell lymphoblastic
lymphoma. This purine nucleoside analog is used
in patients whose disease has not gotten better
or whose cancer has come back after treatment
with other existing anticancer medicines.
Nelarabine injection is an intravenous
medication. This means it is administered through
a tube in your vein. Respective patients (adults
and children) should not drive or operate any
dangerous machines. Nelarabine may be responsible
for causing sleepiness during and for several
days after treatment. Patients (both adults and
children) should not receive vaccines developed
with live germs during Nelarabine therapy.
Nelarabine inhibits cells from making DNA and may
kill the malignant cells. It is a sort of
antimetabolite. Also called 506U78.

• NELARABINE DRUG INFORMATION FOR PATIENTS

4
(No Transcript)